Results for tag: "Renal Failure Drug"

The Renal Failure Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat renal failure, a condition in which the kidneys are unable to filter waste from the blood. These drugs are used to reduce the amount of waste in the blood, as well as to reduce the risk of complications associated with renal failure. Common drugs used to treat renal failure include diuretics, ACE inhibitors, and angiotensin receptor blockers. Additionally, drugs such as erythropoietin and iron supplements are used to treat anemia, a common complication of renal failure. Some companies in the Renal Failure Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more